← 返回

识别关键免疫基因 NR1H4 和 IL4R 作为区分卵巢透明细胞癌与高级别浆液性癌的诊断生物标志物

英文原题:Recognition of pivotal immune genes NR1H4 and IL4R as diagnostic biomarkers in distinguishing ovarian clear cell cancer from high-grade serous cancer.

查看英文原题

Recognition of pivotal immune genes NR1H4 and IL4R as diagnostic biomarkers in distinguishing ovarian clear cell cancer from high-grade serous cancer.

PubMed 2025/06/27(内容时间) Front Mol Biosci Q2 · IF 4.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

NR1H4 和 IL4R 是 OCCC 有前景的免疫相关诊断生物标志物,可能在中性粒细胞介导的肿瘤微环境调控中发挥作用。这些发现增进了对 OCCC 发病机制的理解,并为开发靶向诊断工具和免疫治疗策略提供了基础。

研究思路结论见上方概要

卵巢透明细胞癌(OCCC)以预后差和缺乏早期诊断标志物为特征。识别OCCC与更常见的高级别浆液性卵巢癌(HGSC)之间的分子差异,对于开发靶向诊断和治疗策略以改善临床结局至关重要。

我们从Gene Expression Omnibus (GEO)数据库中获取了OCCC和HGSC的mRNA表达谱。为了识别与OCCC相关的差异免疫相关基因(DIRGs)。我们评估了DIRGs的功能富集,并构建了蛋白质-蛋白质相互作用(PPI)网络以探索DIRGs之间的相互作用。应用最小绝对收缩和选择算子(LASSO)回归模型和多支持向量机递归特征消除(mSVM-RFE)方法识别预测基因。使用受试者工作特征(ROC)曲线评估这些候选基因的诊断性能。构建列线图以预测OCCC。我们进一步通过验证集和免疫组织化学(IHC)验证了关键DIRGs的诊断能力。使用CIBERSORT算法分析OCCC中DIRGs与免疫细胞类型之间的相关性。

我们在OCCC中检测到10个DIRGs,与HGSC相比。这些基因主要与富含胶原的细胞外基质、Phosphoinositide-3 Kinase- Protein Kinase B (PI3K-AKT)通路以及癌症中的转录失调相关。Nuclear receptor subfamily 1 group H member 4 (NR1H4)和Interleukin-4 Receptor (IL4R)成为OCCC的潜在生物标志物(AUC NR1H4 = 0.809;AUC IL4R = 0.840)。在验证队列中,AUC NR1H4 = 0.848,AUC IL4R = 0.821。IHC显示OCCC中NR1H4和IL4R的表达水平较高(P < 0.05)。此外,NR1H4与静息记忆T细胞和中性粒细胞呈正相关,而IL4R与静息Natural Killer (NK)细胞和中性粒细胞相关。

展开英文摘要原文

Ovarian clear cell carcinoma (OCCC) is characterized by poor prognosis and limited early diagnostic markers. Identifying molecular distinctions between OCCC and the more common high-grade serous ovarian cancer (HGSC) is critical to developing targeted diagnostic and therapeutic strategies for improved clinical outcomes.

We retrieved the mRNA expression profiles of OCCC and HGSC from the Gene Expression Omnibus (GEO) database. To identify differentially immune-related genes (DIRGs) linked to OCCC. We assessed DIRGs functional enrichment and built a protein-protein interaction (PPI) to explore DIRGs interactions. Least Absolute Shrinkage and Selection Operator (LASSO) regression model and Multiple Support Vector Machine Recursive Feature Elimination (mSVM-RFE) methods were applied to identify predictive genes. The diagnostic performance of these candidate genes was evaluated using receiver operating characteristic (ROC) curves. A nomogram was constructed to predict OCCC. We further validated key DIRGs' diagnostic ability via a validation set and immunohistochemistry (IHC). The CIBERSORT algorithm was used to analyze correlations between DIRGs and immune cell types in OCCC.

We detected 10 DIRGs in OCCC compared to HGSC. These genes were mainly linked to collagen-rich extracellular matrix, Phosphoinositide-3 Kinase- Protein Kinase B (PI3K-AKT) pathway, and transcriptional dysregulation in cancer. Nuclear receptor subfamily 1 group H member 4 (NR1H4) and Interleukin-4 Receptor (IL4R) emerged as potential biomarkers for OCCC (AUC NR1H4 = 0.809; AUC IL4R = 0.840). In the validation cohort, AUC NR1H4 = 0.848 and AUC IL4R = 0.821, respectively. IHC revealed higher expression levels of NR1H4 and IL4R in OCCC (P < 0.05). Additionally, NR1H4 correlated positively with resting memory T cells and neutrophils, while IL4R correlated with resting Natural Killer (NK) cells and neutrophils.

NR1H4 and IL4R are promising immune-related diagnostic biomarkers for OCCC, with potential roles in neutrophil-mediated tumor microenvironment modulation. These findings enhance understanding of OCCC pathogenesis and provide a foundation for developing targeted diagnostic tools and immunotherapeutic strategies.

论文信息

作者
Ke Y、Liang M、Zhou Z、Xie Y、Huang L、Sheng L、Wang Y、Zhou X
单位
Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.China
期刊
Frontiers in molecular biosciences2025
原文标识
PubMed 40656893 · DOI 10.3389/fmolb.2025.1600808